Last reviewed · How we verify

NCT07084649

Dual-target iTBS for Youth With ADHD

Recruiting now Phase 1, PHASE2 Last updated 24 July 2025
What this trial tests

Phase 1, PHASE2 trial testing TMS in ADHD in 15 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
1 September 2026
30 December 2026

Quick facts

Lead sponsorShanghai Mental Health Center
PhasePhase 1, PHASE2
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date1 January 2025
Primary completion1 September 2026
Estimated completion30 December 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai Mental Health Center — full company profile →

Who can join

Adults 10 to 18, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will employ accelerated intermittent theta burst stimulation (aiTBS) targeting two transcranial magnetic stimulation (TMS) sites: the right inferior frontal gyrus and left inferior parietal lobule.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of TMS

Trials testing the same drug.

Other recruiting trials for ADHD

Currently open trials in the same condition.

Other Shanghai Mental Health Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07084649.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing